BG108072A - The use of epothilone derivatives for the treatment of refractory tumors - Google Patents
The use of epothilone derivatives for the treatment of refractory tumorsInfo
- Publication number
- BG108072A BG108072A BG108072A BG10807203A BG108072A BG 108072 A BG108072 A BG 108072A BG 108072 A BG108072 A BG 108072A BG 10807203 A BG10807203 A BG 10807203A BG 108072 A BG108072 A BG 108072A
- Authority
- BG
- Bulgaria
- Prior art keywords
- treatment
- epothilone
- derivatives
- epothilone derivatives
- refractory tumors
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 150000003883 epothilone derivatives Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 229940123237 Taxane Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229930013356 epothilone Natural products 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26985801P | 2001-02-20 | 2001-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG108072A true BG108072A (en) | 2005-04-30 |
Family
ID=23028941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG108072A BG108072A (en) | 2001-02-20 | 2003-08-07 | The use of epothilone derivatives for the treatment of refractory tumors |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6727276B2 (et) |
| EP (1) | EP1368030A1 (et) |
| JP (1) | JP2004522771A (et) |
| KR (1) | KR20040028720A (et) |
| CN (1) | CN1610549A (et) |
| BG (1) | BG108072A (et) |
| BR (1) | BR0207316A (et) |
| CA (1) | CA2438598A1 (et) |
| EE (1) | EE200300397A (et) |
| HU (1) | HUP0400041A2 (et) |
| IL (1) | IL157128A0 (et) |
| IS (1) | IS6917A (et) |
| MX (1) | MXPA03007423A (et) |
| NO (1) | NO20033682D0 (et) |
| PL (1) | PL363363A1 (et) |
| RU (1) | RU2003128312A (et) |
| WO (1) | WO2002066033A1 (et) |
| ZA (1) | ZA200306237B (et) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2273083C (en) | 1996-12-03 | 2012-09-18 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US20050043376A1 (en) * | 1996-12-03 | 2005-02-24 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US6204388B1 (en) * | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6780620B1 (en) * | 1998-12-23 | 2004-08-24 | Bristol-Myers Squibb Company | Microbial transformation method for the preparation of an epothilone |
| US20020058286A1 (en) * | 1999-02-24 | 2002-05-16 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto and analogues thereof |
| IL157443A0 (en) * | 2001-03-14 | 2004-03-28 | Bristol Myers Squibb Co | Pharmaceutical compositions for the treatment of cancer including an epothilone analog and a chemotherapeutic agent |
| TW200403994A (en) * | 2002-04-04 | 2004-03-16 | Bristol Myers Squibb Co | Oral administration of EPOTHILONES |
| TW200400191A (en) * | 2002-05-15 | 2004-01-01 | Bristol Myers Squibb Co | Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US7384964B2 (en) * | 2002-08-23 | 2008-06-10 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| PT1506203E (pt) | 2002-08-23 | 2007-04-30 | Sloan Kettering Inst Cancer | Síntese de epotilonas, seus intermediários, seus análogos e suas utilizações |
| AU2003279911A1 (en) | 2002-10-09 | 2004-05-04 | Kosan Biosciences, Inc. | Therapeutic formulations |
| US20050171167A1 (en) * | 2003-11-04 | 2005-08-04 | Haby Thomas A. | Process and formulation containing epothilones and analogs thereof |
| US20050215604A1 (en) * | 2004-03-26 | 2005-09-29 | Kosan Biosciences, Inc. | Combination therapies with epothilones and carboplatin |
| MX2007005763A (es) * | 2004-11-18 | 2007-07-20 | Squibb Bristol Myers Co | Perla recubierta enterica que comprende ixabepilona, y preparacion y administracion de la misma. |
| EP1824458A1 (en) * | 2004-11-18 | 2007-08-29 | Bristol-Myers Squibb Company | Enteric coated bead comprising epothilone or an epothilone analog, and preparation and administration thereof |
| EP2634252B1 (en) | 2005-02-11 | 2018-12-19 | University of Southern California | Method of expressing proteins with disulfide bridges |
| CA2607940C (en) | 2005-05-18 | 2009-12-15 | Aegera Therapeutics Inc. | Bir domain binding compounds |
| WO2007130501A2 (en) | 2006-05-01 | 2007-11-15 | University Of Southern California | Combination therapy for treatment of cancer |
| SG10201407457UA (en) | 2006-05-16 | 2014-12-30 | Pharmascience Inc | Iap bir domain binding compounds |
| US8802394B2 (en) | 2008-11-13 | 2014-08-12 | Radu O. Minea | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
| KR20120140658A (ko) | 2010-02-12 | 2012-12-31 | 파마사이언스 인크. | Ｉａｐ ｂｉｒ 도메인 결합 화합물 |
| EP2571525A4 (en) | 2010-05-18 | 2016-04-27 | Cerulean Pharma Inc | Compositions and methods for treating autoimmune and other diseases |
| CN110105368B (zh) * | 2019-05-09 | 2022-01-07 | 上海大学 | 去氧紫杉烷类似物及其制备方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
| DE19542986A1 (de) | 1995-11-17 | 1997-05-22 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Verwendung |
| PT1186606E (pt) | 1995-11-17 | 2004-08-31 | Biotechnolog Forschung Mbh Gbf | Derivados do epotilone sua preparacao e utilizacao |
| DE19639456A1 (de) | 1996-09-25 | 1998-03-26 | Biotechnolog Forschung Gmbh | Epothilon-Derivate, Herstellung und Mittel |
| NZ334821A (en) | 1996-08-30 | 2000-12-22 | Novartis Ag | Method for producing epothilones |
| DE19645361A1 (de) | 1996-08-30 | 1998-04-30 | Ciba Geigy Ag | Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II |
| DE19645362A1 (de) | 1996-10-28 | 1998-04-30 | Ciba Geigy Ag | Verfahren zur Herstellung von Epothilon A und B und Derivaten |
| US5969145A (en) * | 1996-08-30 | 1999-10-19 | Novartis Ag | Process for the production of epothilones and intermediate products within the process |
| DK0941227T5 (da) | 1996-11-18 | 2009-10-05 | Biotechnolog Forschung Gmbh | Epothilon D, dens fremstilling samt dens anvendelse som cytostatisk middel og som plantebeskyttelsesmiddel |
| US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| CA2273083C (en) * | 1996-12-03 | 2012-09-18 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6380394B1 (en) | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
| US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
| DE19701758A1 (de) | 1997-01-20 | 1998-07-23 | Wessjohann Ludgar A Dr | Epothilone-Synthesebausteine |
| CN1128803C (zh) | 1997-02-25 | 2003-11-26 | 生物技术研究有限公司(Gbf) | 环氧噻嗪酮b－n－氧化物及其制备方法 |
| DE19713970B4 (de) | 1997-04-04 | 2006-08-31 | R&D-Biopharmaceuticals Gmbh | Epothilone-Synthesebausteine II - Prenylderivate |
| EP0975622B1 (de) | 1997-04-18 | 2002-10-09 | Studiengesellschaft Kohle mbH | Selektive olefinmetathese von bi- oder polyfunktionellen substraten in komprimiertem kohlendioxid als reaktionsmedium |
| DE19821954A1 (de) | 1997-05-15 | 1998-11-19 | Biotechnolog Forschung Gmbh | Verfahren zur Herstellung eines Epothilon-Derivats |
| DE19720312A1 (de) | 1997-05-15 | 1998-11-19 | Hoechst Ag | Zubereitung mit erhöhter in vivo Verträglichkeit |
| DE19726627A1 (de) | 1997-06-17 | 1998-12-24 | Schering Ag | Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon |
| US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
| PT1001951E (pt) | 1997-07-16 | 2003-02-28 | Schering Ag | Derivados de tiazolo, processo para a sua preparacao e utilizacao |
| US7407975B2 (en) | 1997-08-09 | 2008-08-05 | Bayer Schering Pharma Ag | Epothilone derivatives, method for producing same and their pharmaceutical use |
| US6365749B1 (en) | 1997-12-04 | 2002-04-02 | Bristol-Myers Squibb Company | Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| AU753519B2 (en) | 1998-02-05 | 2002-10-17 | Novartis Ag | Compositions containing organic compounds |
| US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
| CA2322157C (en) | 1998-02-25 | 2012-05-29 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| FR2775187B1 (fr) | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
| US6380395B1 (en) | 1998-04-21 | 2002-04-30 | Bristol-Myers Squibb Company | 12, 13-cyclopropane epothilone derivatives |
| AU5036999A (en) | 1998-06-30 | 2000-01-17 | Schering Aktiengesellschaft | Epothilon derivatives, their preparation process, intermediate products and their pharmaceutical use |
| NZ511722A (en) | 1998-11-20 | 2004-05-28 | Kosan Biosciences Inc | Recombinant methods and materials for producing epothilone and epothilone derivatives |
| BR9916833A (pt) | 1998-12-22 | 2001-09-25 | Novartis Ag | Derivados de epotilona e seu uso como agentes antitumor |
| DE50014587D1 (de) | 1999-02-18 | 2007-10-04 | Bayer Schering Pharma Ag | 16-halogen-epothilon-derivate, verfahren zu deren herstellung und ihre pharmazeutische verwendung |
| KR100685336B1 (ko) * | 1999-02-22 | 2007-02-23 | 게젤샤프트 퓌어 비오테크놀로기쉐 포르슝 엠베하(게베에프) | Ｃ-21 변형 에포틸론 |
| US6211412B1 (en) | 1999-03-29 | 2001-04-03 | The University Of Kansas | Synthesis of epothilones |
| AR023792A1 (es) | 1999-04-30 | 2002-09-04 | Bayer Schering Pharma Ag | Derivados 6-alquenilo- y 6-alquinilo-epotilona, los procedimientos para prepararlos y su empleo en productos farmaceuticos |
-
2002
- 2002-02-06 MX MXPA03007423A patent/MXPA03007423A/es unknown
- 2002-02-06 WO PCT/US2002/004247 patent/WO2002066033A1/en not_active Ceased
- 2002-02-06 EP EP02724940A patent/EP1368030A1/en not_active Withdrawn
- 2002-02-06 BR BR0207316-1A patent/BR0207316A/pt not_active Application Discontinuation
- 2002-02-06 CA CA002438598A patent/CA2438598A1/en not_active Abandoned
- 2002-02-06 RU RU2003128312/14A patent/RU2003128312A/ru not_active Application Discontinuation
- 2002-02-06 JP JP2002565591A patent/JP2004522771A/ja active Pending
- 2002-02-06 IL IL15712802A patent/IL157128A0/xx unknown
- 2002-02-06 CN CNA028052447A patent/CN1610549A/zh active Pending
- 2002-02-06 EE EEP200300397A patent/EE200300397A/et unknown
- 2002-02-06 PL PL02363363A patent/PL363363A1/xx not_active Application Discontinuation
- 2002-02-06 HU HU0400041A patent/HUP0400041A2/hu unknown
- 2002-02-06 KR KR10-2003-7010872A patent/KR20040028720A/ko not_active Withdrawn
- 2002-02-08 US US10/071,988 patent/US6727276B2/en not_active Expired - Fee Related
-
2003
- 2003-08-07 BG BG108072A patent/BG108072A/xx unknown
- 2003-08-12 ZA ZA200306237A patent/ZA200306237B/en unknown
- 2003-08-18 IS IS6917A patent/IS6917A/is unknown
- 2003-08-19 NO NO20033682A patent/NO20033682D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200306237B (en) | 2004-12-23 |
| US20020165257A1 (en) | 2002-11-07 |
| US6727276B2 (en) | 2004-04-27 |
| MXPA03007423A (es) | 2003-11-18 |
| CA2438598A1 (en) | 2002-08-29 |
| NO20033682L (no) | 2003-08-19 |
| IS6917A (is) | 2003-08-18 |
| KR20040028720A (ko) | 2004-04-03 |
| EP1368030A1 (en) | 2003-12-10 |
| WO2002066033A1 (en) | 2002-08-29 |
| HUP0400041A2 (hu) | 2004-04-28 |
| NO20033682D0 (no) | 2003-08-19 |
| JP2004522771A (ja) | 2004-07-29 |
| BR0207316A (pt) | 2004-02-10 |
| EE200300397A (et) | 2003-12-15 |
| RU2003128312A (ru) | 2005-02-10 |
| IL157128A0 (en) | 2004-02-08 |
| PL363363A1 (en) | 2004-11-15 |
| CN1610549A (zh) | 2005-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG108072A (en) | The use of epothilone derivatives for the treatment of refractory tumors | |
| CZ309247B6 (cs) | 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru | |
| ZA200305126B (en) | Methods of administering epothilone analogs for the treatment of cancer. | |
| IL244727A0 (en) | Methods and preparations using immunomodulatory compounds for the treatment and management of cancer and other diseases | |
| WO2003070163A3 (en) | Prostacyclin derivatives for treating cancer | |
| IL175714A0 (en) | Quinazolinone compounds as anticancer agents | |
| PL2484365T3 (pl) | Kompozycje i sposoby leczenia chorób neowaskularnych | |
| EP1017675A4 (en) | HIGHLY LIPOPHILIC CAMPTOTHECIN DERIVATIVES | |
| HK1041256A1 (zh) | 靛系双吲衍生物 | |
| TW200626138A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
| AU2002321105A1 (en) | Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis | |
| WO2004045593A3 (en) | Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy | |
| MXPA04004606A (es) | Venenos de topoisomerasa solubilizados. | |
| SE9903997D0 (sv) | New compounds | |
| MXPA05012953A (es) | Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos. | |
| EP1458734A4 (en) | ISOINDIGO, INDIGO AND INDIRUBIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER | |
| WO2002070515A3 (en) | Chromane derivatives, process for their preparation and their use as antitumor agents | |
| EP1262197A3 (en) | Combination treatment for sleep disorders including sleep apnea | |
| ATE424200T1 (de) | Solubilisierte topoisomerase-gift-mittel | |
| AU2162202A (en) | Antitumor therapy comprising distamycin derivatives | |
| TW200603804A (en) | Treatment with irinotecan (cpt-11) and an EGFR-inhibitor | |
| MXPA03006412A (es) | Metodos para administrar analogos de epotilona para tratamiento de cancer. | |
| WO2003076445A3 (en) | Microtubule stabilizing compounds | |
| WO2002074756A3 (de) | Urokinase-inhibitoren | |
| TW200504051A (en) | Novel acridine derivatives and their use as medicaments |